BioSpace News Archive

Therapix Biosciences Announces Expansion Into Precision Medicine Through New Fully-Owned Subsidiary and Provides Corporate Update Today at the Biotech Showcase™ 2018

This new subsidiary will complement the Company’s cannabinoid-based drug development strategy.

January 9, 2018
·
4 min read
Business

Radient Technologies Inc. Provides Corporate Update and Announces Real Estate Expansion

The Facility is fully GMP compliant with a pending ACMPR license expected to be issued by Health Canada later this year.

January 9, 2018
·
7 min read
Policy

InflaRx Receives IND Acceptance To Proceed With A Phase IIb Trial With Lead Candidate IFX-1 In Hidradenitis Suppurativa

The open IND will allow InflaRx to conduct a phase IIb study to determine efficacy and safety of IFX-1, a first-in-class anti-human complement factor C5a antibody, in patients with moderate or severe Hidradenitis Suppurativa.

January 9, 2018
·
4 min read
Business

Medical Research Collaborating Center Selects Medidata to Meet Global Regulatory Requirements During Clinical Trials

Medidata today announced that the Medical Research Collaborating Center (MRCC), one of the leading research centers of biomedical science in South Korea, has selected Medidata Rave® to accelerate the overall regulatory data submission process during clinical trials.

January 9, 2018
·
3 min read
BioProtect Launches an International Multi-Center Clinical Study Following FDA IDE

The trial is a prospective, randomized study to demonstrate the safety and efficacy of the ProSpace biodegradable spacer to protect the rectum and lower GI tract during radiation therapy for prostate cancer compared to patients without any spacers.

January 9, 2018
·
2 min read
Business

WuXi NextCODE Artificial Intelligence Used to Advance Precision Therapy for Rare Genetic Disorders of Obesity

The first phase of the partnership involved mining WuXi NextCODE’s knowledgebase of all major reference datasets to identify all rare sequence variants in the POMC, PCSK1, and LEPR genes in the MC4R pathway.

January 9, 2018
·
4 min read
Business

Two Pore Guys and Maxim Integrated Announce Technology Collaboration and Investment

As part of this collaboration, Maxim has invested in 2PG through its venture arm Maxim Ventures.

January 9, 2018
·
4 min read
Drug Development

Positive Results From a Multi-Center Analysis of Delcath PHP Therapy Published in Journal of Surgical Oncology

Patients in the study were treated at the two centers between December 2008 and October 2016.

January 9, 2018
·
6 min read
Drug Development

FDA Calls Bay Area Global Blood Therapeutics’ Sickle Cell Drug a Breakthrough

The BTD decision for voxelotor was based on clinical data submitted from a trio of studies.

January 9, 2018
·
6 min read
Business

Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results

Full year 2017 estimated sales are expected to be approximately $635.4 million, an increase of 12.7% over the prior year.

January 9, 2018
·
8 min read